Pharmacology of airways and vessels in lung slices in situ: Role of endogenous dilator hormones by Moreno, Laura et al.
This Provisional PDF corresponds to the article as it appeared upon acceptance. Copyedited and
fully formatted PDF and full text (HTML) versions will be made available soon.
Pharmacology of airways and vessels in lung slices in situ: role of endogenous
dilator hormones
Respiratory Research 2006, 7:111 doi:10.1186/1465-9921-7-111
Laura Moreno (lmoreno@ift.csic.es)
Francisco Perez-Vizcaino (fperez@med.ucm.es)
Louise Harrington (l.harrington@qmul.ac.uk)
Renato Faro (rfaro@cartesius.com)
Graham Sturton (g.sturton@imperial.ac.uk)
Peter J Barnes (p.j.barnes@imperial.ac.uk)
Jane A Mitchell (j.a.mitchell@ic.ac.uk)
ISSN 1465-9921
Article type Research
Submission date 25 January 2006
Acceptance date 21 August 2006
Publication date 21 August 2006
Article URL http://respiratory-research.com/content/7/1/111
This peer-reviewed article was published immediately upon acceptance. It can be downloaded,
printed and distributed freely for any purposes (see copyright notice below).
Articles in Respiratory Research are listed in PubMed and archived at PubMed Central.
For information about publishing your research in Respiratory Research or any BioMed Central
journal, go to
http://respiratory-research.com/info/instructions/
For information about other BioMed Central publications go to
http://www.biomedcentral.com/
Respiratory Research
© 2006 Moreno et al., licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 1
Pharmacology of airways and vessels in lung slices in situ: role of endogenous dilator 
hormones 
L. Moreno, F. Perez-Vizcaino, L. Harrington, R. Faro, G. Sturton, PJ Barnes and JA 
Mitchell. 
 
Cardiothoracic Pharmacology, and Airway Disease Section, National Heart & Lung 
Institute, Imperial College London, Dovehouse Street SW3 6LY U.K.  
L.M. lmoreno@ift.csic.es 
F. P.-V. lmoreno@ift.csic.es 
L.H. l.harrington@qmul.ac.uk 
R. F. rfaro@cartesius.com 
G. S. g.sturton@imperial.ac.uk 
P.J.B. p.j.barnes@imperial.ac.uk 
J.A.M. j.a.mitchell@ic.ac.uk 
Correspondence to: 
Jane A. Mitchell, 
Cardiothoracic Pharmacology, 
Unit of Critical Care Medicine, 
Imperial College London, 
Royal Brompton Hospital, NHLI, 
Dovehouse Street, 
London SW36LY 
e-mail: j.a.mithell@ic.ac.uk 
Phone: 07973520149 
 2
Abstract 
Small airway and vessels play a critical role in chronic airway and pulmonary vascular 
diseases, but their pharmacology has not been well characterised. We have studied airway 
and vascular responses in rat lung slices and separately in vitro using myography.  In lung 
slices, under basal conditions, acetylcholine contracted airways, but had no vascular effect. 
The thromboxane mimetic, U46619 contracted both vessels and airways. In the presence of 
U46619, acetylcholine dilated vessels, but further contracted airways, an effect that was 
blocked by the nitric oxide synthase inhibitor L-N
G
-nitro-L-arginine or apamin plus 
charybdotoxin, which inhibit endothelial-derived hyperpolarising factor. Airway responses 
in lung slices were unaffected by L-N
G
nitro-L-arginine methyl ester, indomethacin or 
apamin plus charybdotoxin.  By contrast, apamin plus charybdotoxin contracted bronchi 
studied in isolation.  Our observations are the first to identify mechanisms of endothelium 
dependent dilations in precision cut lung slices and the potential for transverse hormonal 
communication between airways and vessels.   
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Background 
In mammals the lung is made up of conducting airways that carry air to the alveoli, the gas-
exchanging units of the lung. The airways branch from the hilum towards the periphery. 
From the trachea to the terminal airways the diameter decreases but there is a gradual 
increase in cross-sectional area, because of the increase in number of airways [1]. In the 
adult lung the pulmonary arteries run alongside the airways, branching with them and 
decreasing in diameter. They supply blood to the capillary area closely matching that of the 
alveolar surface area. The pulmonary veins drain the capillary bed and though they do not 
run alongside the airways they have an equivalent number of branches to the arteries. The 
close relationship of the blood vessels and the airways is found throughout the lung. 
However our understanding how they function in parallel in situ is incomplete.  
 Acetylcholine dilates blood vessels [2] via activation of the endothelium and the 
subsequent release of NO, prostacyclin and endothelial-derived hyperpolarizing factor 
(EDHF), [3]. Acetylcholine constricts airways through activation of muscarinic receptors 
on airway smooth muscle cells [4]. However, it has been suggested that a bronchodilator is 
released by the epithelium and that this ‘factor’ could be NO [5]. Tonic responses of 
airways or pulmonary vessels are general studied separately, in isolation using organ baths. 
In addition, some groups have investigated tonic responses in airways [6], [7], [8], [9]) or  
pulmonary vessels [10], [11] in situ in whole lung slices using agonists. Methods applied to 
study airway and vascular responses in the whole lung slices rely on the infusion of a 
scaffold material such as agarose to facilitate the efficient sectioning of the tissue. 
Functional endothelial-dependent responses have been demonstrated in arteries and veins of 
guinea-pig lung slices, although comparisons with airway responses have not been made 
[12]. There are no studies in which responses in airways and vessels have been monitored 
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simultaneously and where the role of endogenous dilator hormones (e.g. NO) released by 
either vascular endothelium, or airway epithelium, in responses have been addressed. In the 
current study we have measured the contractile and relaxant responses of airways and 
vessels in situ in whole lung slices using video microscopy [13]. Acetylcholine was added 
to the tissue in the presence and absence of a constrictor agent. The respective roles of NO, 
prostacyclin or EDHF in airway or vascular responses were addressed by pharmacological 
inhibitors. Finally, in each case, we have compared responses of vessels and airways in 
whole lung slices with those obtained using isolated structures in in vitro using wire 
myographs. 
  
 5
2. Materials and Methods 
2.1. Preparation of lung slices 
Lungs were taken from 6-8 week-old (230-270 g) female Wistar rats and lung slices 
prepared as previously described [13]. All the animals used in this project were maintained 
and killed in accordance with The European Community guidelines for the use of 
experimental animals.  
The animals were killed by lethal exposure to CO2, trachea was cannulated and the 
animals were exsanguinated by cutting the vena cava inferior. A small vertical cut into the 
diaphragm was made to collapse the lungs, followed by immediate instillation of 15 ml of 
2% agarose (low melting point agarose) solution into the airways. After the agarose had 
cooled to 4ºC, tissue cores were prepared by advancing a rotating, sharpened metal tube 
(diameter 8 mm) longitudinally. From these cores, tissue slices (250 µm) were prepared 
using a Krumdieck tissue slicer (Alabama Research and Development, Munford, AL, 
USA). 
These slices were examined with an inverted microscope and those that contained at 
least one cross section of a vessel or an airway were placed in a 12 wells plate containing 1 
ml of Dulbecco´s modified Eagle’s Medium (DMEM) supplemented with 100 units.ml
-1
 
penicillin, 0.1mg.ml
-1
 steptomycin, 4mM L-glutamine and 2.5µg.ml
-1
 aphotericin B and 
incubated overnight on a roller system housed in a humidified incubator (37ºC, 5% CO2-
95% air). Medium was changed every 45 minutes for the first 3 hours. Sections of lung 
containing 2/3
rd
 order airways and vessels were taken in order to parallel the structures 
studied in isolation using the myographs (see below). 
 
 6
 
2.2.  Image acquisition 
Incubation and observation of slices was carried on an incubator chamber (PCLS-
Bath Type 847, Hugo Sachs elektronik, Harvard Apparatus GmgH) containing 0.4ml 
complete DMEM placed on the stage of a microscope (Nikon SMZ-U) and warmed to 
37ºC. 
Arteries and airways were identified and imaged with a video camera (Image 
Associates, UK). To distinguish arteries from veins, we used criteria similar to those 
described previously [11]: 1) The arteries usually accompanied airways, whereas veins 
where at a distance from them, and 2) arterial walls had a thick media and their inner lining 
was slightly wrinkled, whereas veins were thinner and wrinkles were inconspicuous.    
 
2.3. Experimental design 
After preincubation for 5 minutes with 0.5 ml of DMEM, the first image was acquired 
(“baseline image"). Then, the liquid was removed and fresh medium added containing 
acetylcholine (10
-5
M). The slice was imaged every 20 seconds for 6 minutes followed by a 
wash step which led to a return to baseline. Then airways and vessels were precontracted 
with the thromboxane analogue 9,11-Dideoxy-11α, 9α-epoxymethanoprostaglandin F2α 
(U46619, 10
-7
M) and again images recorded every 20 seconds for 6 minutes. Acetylcholine 
(10
-5
M) was then added for 5 min, with images recorded each 20 sec. In some experiments 
acetylcholine was added to U46619 constricted airways and vessels in the presence of the 
nitric oxide synthase (NOS) inhibitor L-N
G
nitro-L-arginine methyl ester (L-NAME; 10
-
3
M), the combined cyclo-oxygenase-1/cyclo-oxygenase-2 inhibitor indomethacin (10
-5
M) 
or the combination of apamin and charybdotoxin (5x10
-7
M and 10
-7
M) which together 
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inhibit EDHF release (18) . For these experiments incubations were continued for 10 
minutes with images recorded each 20 seconds as above.  
 
2.4. Image analysis 
The images were analysed using an image analysis program (ZEISS KS 300 3.0). The 
luminal area was taken as the area enclosed by the epithelial luminal border and was 
quantified after setting the appropriate threshold value.  
Baseline area was defined as 100%. The responses of arteries and airways were 
calculated as a percentage of baseline area using the equation: Response = residual area 
after drug/baseline area X 100. Thus a 0% response indicated complete luminal closure and 
100% indicated no effect. 
 
2.5. Myography 
In lungs from separate animals, second- to third-order branch pulmonary arteries or bronchi 
were isolated from the lungs of female Wistar rats and placed into modified Krebs buffer 
(composition in 10
-3
M): NaCl 119, KCl 4.7, CaCl2, 2.5, MgSO4 1.17, NaHCO3 25, KH2PO4 
1.18, EDTA 0.027 and glucose 5.5. 
 Pulmonary artery and bronchi were dissected our of fresh lungs and cut into small 
segments and mounted in a four channel Mulvanny-Halpern myograph under normalised 
tension (7.5 kPa) [14] .The segments were first challenged with high potassium solution 
(composition in 10
-3
M: KCl 123.7, CaCl2. 2.5, MgSO4 1.17, NaHCO3 25, KH2PO4 1.18, 
EDTA 0.027 and glucose 5.5). Tissues were then washed and incubated once again in 
Krebs buffer. 
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 Concentration-response curves to either U46619 (10
-9
 to 10
-6
M) or acetylcholine 
(10
-8
 to 10
-5
M) were then carried out and contractile responses in both airways or vessels 
recorded and represented as active effective pressure (AEP; Kpa; mN/mm
2
), calculated by 
the following equations: ∆T=∆F/2x segment length; AET=∆T/ vessel radius where ∆T 
represent active wall tension and ∆F represents active force response measured in mN. 
Airways or vessels were then pre-contracted with an EC80 concentration of U46619 and 
acetylcholine added (10
-5
M). Responses were allowed to plateau before individual 
inhibitors of the NO, prostacyclin or EDRF pathways add, these were L-NAME (10
-3
M), 
indomethacin (10
-5
M) or apamin (5x10
-7
M) plus charybdotoxin (10
-7
M), (18) respectively.  
 Relaxant responses were calculated as a percentage of U46619-induced tone. Data 
are given as the mean±SEM. 
 
2.7. Materials 
All drugs were purchased from Sigma Gilligham, Dorset, UK. Acetylcholine and 
indomethacin were freshly prepared each day in aqueous and ethanol solutions, 
respectively. U46619 was prepared in high concentration “stock” solution dissolved in 
ethanol and was stored at –80ºC until used. 
 
2.8. Statistics 
Data was analysed using the appropriate tests and GraphPad Software. T-tests, one-way 
analysis of variance or one-sample T-test for normalised data was used as described in the 
text or in the figure legends. 
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3. Results 
3.1. Effects of acetylcholine and U46619 on airway and vascular responses in precision cut 
lung slices in situ 
Acetylcholine contracted airways (10
-5
M; -29.4±7.3%) but had no significant effect 
(103.7±1.7%) on ‘basal’ pulmonary vessel luminal area (n=6). The thromboxane mimetic 
U46619 (10
-7
M) contracted both vessels (-37.8±0.7%) and airways (-39.5±1.9%) (Figure 1 
and 2). Furthermore, in the presence of U46619, acetylcholine (10
-5
 M) dilated the vessel 
but further contracted the airway (Figure 1 and 2). In separate experiments it was found that 
L-NAME (10
-3
M, % control; airway, 81.9±7.4%: vessel 95.1±6.6), indomethacin (10
-5
M; 
airway, 100.8±7.63: vessel 92.4±12.64) or apamin plus charybdotoxin (5x10
-7
M and 10
-7
M; 
airway, 96.3±7.71; vessel, 89.1±5.2) had no significant effect (using one-sample t-test; 
GraphPad) on basal airway or vascular tone (n=4). However, L-NAME and the 
combination of apamin (5x10
-7
M) plus charybdotoxin (10
-7
M) blocked the vasodilator 
effects of acetylcholine in pre-constricted pulmonary vessels in lung slices (Figure 2 and 
Figure 3). Neither L-NAME nor apamin plus charybdotoxin affected contractile responses 
to U46619 or acetylcholine in airways in lung slices (Figure 2 and Figure 3). Indomethacin 
(10
-5
M) had no effect on any responses in either airway or vessel structures in the lung 
slice.   
 
3.2. Effects of U46619 and ACh-induced responses in isolated airways and pulmonary 
arteries preparations in vitro 
U46619 (10
-9
 to 10
-6
M) induced concentration-dependent contractions in either bronchi or 
pulmonary arteries in vitro mounted in myographs (Emax 3.684 ± 0.877mN and 5.306 ± 
 10
0.476mN respectively). For both tissues 10
-7
M of U46619 represented an approximate EC80 
concentration for contraction. Acetylcholine (10
-8
 to 10
-6
M) induced concentration 
dependent contractions of bronchi, but had no effect of pulmonary artery preparations 
(0.355
 
± 0.213mN for 10
-6
M acetylcholine). When pulmonary vessels were pre-contracted 
with U46619 (10
-7
M) acetylcholine induced an immediate and profound and stable 
vasodilator response (Figure 4). When acetylcholine was added to airway tissue, pre-
contracted with U46619, a further contraction was seen (Figure 5). When L-N
G
-nitro-L-
arginine methyl ester (10
-3
M) was added to the pre-constricted vessels, stimulated with 
acetylcholine, it induced a rapid reversal of the dilator response (Figure 4). Similarly, when 
apamin (5x10
-7
M), plus charybdotoxin (10
-7
M), was added in the same way the 
combination of drugs completely reversed acetylcholine induced vasodilatation (Figure 4). 
Apamin plus charybdotoxin had no effect on basal tone in vessels (0% of basal tone). By 
contrast to results obtained in whole lung slices, the combination of apamin plus 
charybdotoxin further contracted airways stimulated with U46619 and acetylcholine 
(Figure 5). 
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4. Discussion 
In the adult lung the pulmonary arteries run alongside the airways, branching with them and 
decreasing in diameter. Indeed, the airways and the vessels share an area of common 
interstitia which may allow transverse communication between the structures. It is therefore 
important to study vascular and airway responses in parallel and in situ. Previously this has 
been achieved using lung slices viewed using a microscope. However the relationship 
between airway and vascular responses to endogenous mediators released by the 
endothelium (or epithelium) has not previously been addressed.  
 Acetylcholine dilates blood vessels [2] via activation of the endothelium and the 
subsequent release of NO, prostacyclin and EDHF [3]. Similarly, whilst acetylcholine 
constricts airways via an action on the smooth muscle, [4] it can also, as in vessels, activate 
the lining cells –namely the epithelium, to release a bronchodilator substance [15], [16]. 
The identity of epithelium-derived relaxing factor is unknown [17], although NO has been 
implicated [5]. In lung slices, we found that, under basal conditions, acetylcholine 
constricted airways, but had no effect on the adjacent pulmonary artery. For blood vessels 
to dilate, they first need to be constricted. Thus, these observations suggest that in lung 
slices either pulmonary vessels have no intrinsic tone or that the endothelium is not 
functional. When the thromboxane mimetic, U46619 was added to the lung slices both the 
airway and the pulmonary artery contracted. Under these conditions, the subsequent 
addition of acetylcholine produced significant dilator responses in the artery, but not in the 
airway of lung slices. These observations are consistent with what we found using isolated 
pulmonary arteries and airways in vitro. In lung slices, the dilator effects of acetylcholine 
on U46619 constriction tissue was blocked by L-NAME or by the combination of apamin 
plus charybdotoxin. L-NAME is a highly selective inhibitor of the NOS family. It inhibits 
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all forms of NOS (NOSI, NOSII and NOSIII). In blood vessels, the release of NO induced 
by activation of the endothelium by agents such as acetylcholine (as used in this study) are 
always mediated by constitutive forms of NOS (principally NOSIII). NO release by NOSII 
is independent of calcium, and so would not by a stimulus such as acetylcholine. We can 
therefore, safely conclude that in lung slices the inhibitory effects we see with L-NAME are 
via the selective inhibition of NOSIII in the endothelium. Our results showing that the 
combination of apamin plus charybdotoxin (inhibitors of small and intermediate potassium 
dependent calcium channels respectively) also inhibited acetylcholine induced 
vasodilatation in vessels in the precision cut lung slice strongly suggest that EDHF is also 
release by these structures. Whilst others have suggested that pulmonary vessels in vitro 
release EDHF along with NO to mediate endothelium dependent dilator responses, we are 
the first to show this occurs in situ. This is an important point because the role of EDHF in 
vascular responses is contentious and not always demonstrable but instead is highly 
dependent upon the experimental conditions applied. These observations show that the 
mechanism of endothelium dependent dilation in lung vessels in precision cut lung sections 
is mediated by NO and EDHF. L-NAME had no effect on airway responses to 
acetylcholine in the absence or presence of U46619. Similarly apamin plus charybdotoxin 
did not influence airway responses in whole lung slices.  
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 Results obtained in lung slices in situ were largely paralleled by responses of 
isolated pulmonary artery or bronchi in vitro. In isolated pulmonary artery preparations, the 
vasodilator effects of acetylcholine were unaffected by indomethacin, suggesting that 
prostacyclin release was not involved in vasodilatation of rat pulmonary artery. In contrast, 
in guinea-pig lung slices, indomethacin increased dilator responses, possibly via the 
inhibition of thromboxane release [11].  
 In isolated preparations acetylcholine had no relaxant effect on U46619-constricted 
airways. Indeed, as was seen in whole lung slices, acetylcholine further contracted U46619 
constricted airways. Interestingly we found that by contrast to results in whole lung slices, 
the combination of apamin plus charybdotoxin further contracted isolated bronchi, pre-
contracted with U46619 and acetylcholine. It is not clear why apamin plus charybdotoxin 
should have constrictor effects (albeit small and indirect) on isolated airway tissue, but not 
on airways in situ, but may be a result of hormonal communication between the structures, 
which would not be present when tissues are separated.  
 In summary, our study is the first to demonstrate functional endothelial responses in 
pulmonary vessels in whole lung slices in situ. We describe a technique whereby vascular 
and airway responses can be studied in parallel in a physiologically superior technique. 
Finally we provide data which suggests that some differences do exist between responses 
(of airways) in lung slices versus in isolation. 
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Figure legends 
Figure 1: 
Effects of U46619 (10
-7
M) and acetylcholine (Ach; 10
-5
M) on internal luminal diameter of 
airway and vessels in whole precision cut lung slices. A; Tissue under control (basal 
conditions) bathed in medium alone. B; Tissue after 6 min stimulation with U46619. C; 
Tissue after 5 min stimulation with U46619 and acetylcholine. The images are 
representative of those used in the pooled data shown in Figure 2. 
 
Figure 2: 
Effects of U46619 (U4; 10
-7
M) and acetylcholine (Ach; 10
-5
M) in the presence or absence 
of L-N
G
-nitro-L-arginine methyl ester (L-NAME) on internal luminal diameter of airway 
and vessels in whole precision cut lung slices. Panel A shows responses in pulmonary 
artery and panel B shows responses in bronchi. Measurements were made under basal 
conditions or after stimulation with U46619 (U4; 10
-7
M) or acetylcholine (Ach; 10
-5
M) or 
U4, plus Ach in the presence of L-NAME. The results are the mean +/- the S.E.M. for n=4-
6 experiments. A p-value of <0.05 was taken as statistically significant, calculated using 
one-way ANOVA and denoted by *.      
 
Figure 3: 
Effects of U46619 (10
-7
M) and acetylcholine (Ach; 10
-6
M), in the presence or absence of 
apamin (Ap, 5x10
-7
) plus charybdotoxin (Ch, 10
-7
M), (Ap+Ch), on internal luminal 
diameter of airway and vessels in whole precision cut lung slices. Panel A shows responses 
in pulmonary artery and panel B shows responses in bronchi. Measurements were made 
under basal conditions or after stimulation with U46619 (U4; 10
-7
M) or acetylcholine (Ach; 
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10
-5
M) or U4, plus Ach in the presence of Ap plus Ch. The results are the mean +/- the 
S.E.M for n=3 experiments. A p-value of <0.05 was taken as statistically significant, 
calculated using one-way ANOVA and denoted by *.  
 
Figure 4: 
Characterisation of the dilator effects of acetylcholine (ACh; 10
-5
M) in isolated pulmonary 
artery.  Panel A shows an original recording from a typical experiment. After equilibration, 
vessels were contracted with U46619 (10
-7
M), at plateau ACh was added and immediate 
dilation occurred. At plateau either L-N
G
-nitro-L-arginine methyl ester (L-NAME; 10
-3
M) 
or apamin (5x10
-7
M) plus charybdotoxin (10
-7
M) was added. Finally where L-NAME had 
been added, apamin plus charybdotoxin were added and visa versa. Panels B and C show 
pooled data from several experiments were L-NAME or apamin plus charybdotoxin were 
added respectively. The data is expressed as the mean percentage of induced tone +/- the 
S.E.M and comprised of n=4-6 experiments. A p-value of <0.05 was taken as statistically 
significant, calculated by t-test and denoted by *.           
 
Figure 5: 
Characterisation of the effects of acetylcholine (ACh; 10
-5
M) in isolated pulmonary bronchi 
pre-constricted with U46619 (U4; 10
-7
M). Panel A shows an original recording from a 
typical experiment. After equilibration, bronchi were contracted with U46619 (10
-7
M), at 
plateau ACh was added and further contraction was observed. At plateau either L-N
G
-nitro-
L-arginine methyl ester (L-NAME; 10
-3
M) or apamin (5x10
-7
M) plus charybdotoxin (10
-
7
M) was added, once a further plateau was achieved apamin plus charybdotoxin or L-
NAME were added respectively. Panels B and C show pooled data from several 
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experiments were L-NAME or apamin plus charybdotoxin individually. The data is 
expresses as the mean percentage of U46619-induced tone +/- the S.E.M and comprised of 
n=4-5 experiments. A p-value of <0.05 was taken as statistically significant, calculated by 
t-test and denoted by *.           
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